Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

M. K. de Vries, E. Brouwer, I. E. van der Horst-Bruinsma*, A. Spoorenberg, J. C. van Denderen, A. Jamnitski, M. T. Nurmohamed, B. A. C. Dijkmans, L. A. Aarden, G. J. Wolbink

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

83 Citations (Scopus)
Original languageEnglish
Pages (from-to)1787-1788
Number of pages2
JournalAnnals of the Rheumatic Diseases
Volume68
Issue number11
DOIs
Publication statusPublished - Nov-2009

Keywords

  • ASAS CONSENSUS STATEMENT
  • RHEUMATOID-ARTHRITIS
  • IMMUNOGENICITY
  • INFLIXIMAB
  • EFFICACY
  • AGENTS

Cite this